Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 21, Number 12—December 2015

Serologic Evidence of Influenza A (H14) Virus Introduction into North America

Cite This Article

To the Editor: Although a diverse population of influenza A viruses (IAVs) is maintained among ducks, geese, shorebirds, and gulls, not all of the 16 avian hemagglutinin (HA) subtypes are equally represented (1). The 14th HA subtype, commonly known as the H14 subtype, was historically limited to isolates from the former Soviet Union in the 1980s (2) and was not subsequently detected until 2010, when isolated in Wisconsin, USA from long-tailed ducks and a white-winged scoter (35). In the United States, the H14 subtype has since been isolated in California (6), Mississippi, and Texas (7); and has been reported in waterfowl in Guatemala (7). In this study, we examined whether there was serologic evidence of H14 spread among ducks in North America before (2006–2010) and after (2011–2014) the initial detection of the H14 subtype virus on this continent.

This report was reviewed and approved by United States Geological Survey under the Fundamental Science Practices policy ( Serum samples from blue-winged teal, American green-winged teal, and mallard ducks were screened by using blocking ELISA (FlockCheck AI MultiS-Screen antibody test kit; IDEXX Laboratories, Westbrook, ME, USA) to detect antibodies against the influenza virus nucleoprotein. Positive samples were tested by microneutralization assays as described (7) against viruses representing H14 and H3 subtypes. H3 is commonly detected in ducks found in North America (8) (online Technical Appendix Table 1,

Antibodies against H3 were detected during 2006–2014 in Michigan, Minnesota, New Jersey, Texas, and Louisiana (Table); titers ranged from 20 to 320. Antibodies against H14 were detected in 1 duck in 2007 and in 24 ducks sampled in 2012 after August. H14 antibodies were detected in all years and most locations studied after 2012; antibody titers ranged from 20 to 160. Thus, antibody prevalence was consistent with the relative prevalence of H3 reported among ducks in North America (1,4,8) and the timing of initial detection of H14 viruses.

To address the possibility of cross-neutralizations between HA subtypes, we tested the 2007 H14-positive serum samples and 22 of the H14-positive serum samples from 2012–2014 against HA subtypes 1–12 (online Technical Appendix Table 1) by virus neutralization (online Technical Appendix Table 2). Among humans, broadly neutralizing antibodies within HA groups targeting conserved regions in the HA stalk have been described (9), and if present in samples from mallards, these could contribute to cross-neutralizations. The H14-positive serum samples from 2007 reacted to subtypes H3, H4, H7, and H11, and high titers were identified for H3 and H4, which are within the same clade. Samples from 17 of these birds tested antibody-positive for additional HA subtypes and 5 tested positive only to H14. An H14 virus was recovered by virus isolation from the same blue-winged teal population sampled in March 2013, from which serum samples were obtained (7); however, although H14 antibodies have been detected in Minnesota, an H14 virus has not yet been isolated in that state.

Our serologic results are temporally consistent with H14 isolation reports and suggest that H14 subtype viruses were not circulating among ducks in North America before initial virus isolation. However, there are potential challenges with serologic-based investigations. For example, the overall prevalence of H14 antibodies after the initial detection of H14 viruses (2011–2014) was low (3.5% of blocking ELISA positive samples), thus requiring a large sample size (n = 670) for H14 antibody detection. However, an even lower prevalence was observed by using virus isolation; we isolated only 1 H14 IAV during parallel sampling of these sites (n = 8,875) during 2011–2014.

Differences in pre- and post-H14 detection also varied between species, location, and season. Differences in H14 antibody prevalence were observed in all ducks sampled pre- and post- (0.3%–3.5%, p = 0.0103) H14 detection, but not in the mallard-only subset (0.3%–2.1%, p = 0.0963). A significant difference in seroprevalence also was detected between species (mallard [2%] vs teal [6%]) in the 2011–2014 samples (p = 0.0104). IAV show strong seasonal patterns in prevalence, and the observed differences in antibodies may be associated with the probability of IAV infection before sampling and the persistence of antibody responses in these species. Mallards (primarily hatch-year birds) were sampled at the beginning of fall migration (≈3–4 months of potential IAV exposure for hatch-year birds), whereas teal were sampled later, during spring migration (≈9–10 months of potential IAV exposure for birds hatched the previous spring or summer). It is apparent that the sampling approach used can affect results.

Interpretation of subtype-specific serologic data can be complex, especially in birds that are normally infected with several IAV subtypes during their lives. Nevertheless, this study demonstrates the value of a subtype-specific serologic approach to detect even relatively minor changes in subtype diversity and clearly shows that new viruses can establish in duck populations in North America. Serologic techniques also can be optimized to detect incursions of novel viruses such as the highly pathogenic Eurasian H5 viruses (10) among wild birds.



We thank B. Wilcox, D. Carter, J. Slusher, N. Davis-Fields, C. Kienzle, G. Knutsen, R. Poulson, P. Link, P. Walther, and G. Newsome for assistance acquiring the serum samples used in this study. We also thank M. Wille and 2 anonymous persons for providing reviews. Positive control antisera were provided by the National Veterinary Services Laboratories, Veterinary Services, United States Department of Agriculture.

The trapping, handling, and sampling of birds was approved through the University of Georgia Institutional Animal Care and Use Committee Animal Use Proposal A2013 05-021.

The work was funded through the National Institute of Allergy and Infectious Diseases, Centers of Excellence for Influenza Research and Surveillance (contract number: HHSN272201400006C) and by the United States Geological Survey through the Wildlife Program of the Ecosystem Mission Area. N.L.-M. was supported by postdoc grants from the Wenner-Gren Foundations, Stockholm, Sweden and the Swedish Research Council.


Neus Latorre-MargalefComments to Author , Andrew M. Ramey, Alinde Fojtik, and David E. Stallknecht
Author affiliations: University of Georgia, Athens, Georgia, USA (N. Latorre-Margalef, A.M. Ramey, A. Fojtik, E. Stallknecht); Lund University, Lund, Sweden (N. Latorre-Margalef); US Geological Survey Alaska Science Center, Anchorage, Alaska, USA (A.M. Ramey)



  1. Olsen  B, Munster  VJ, Wallensten  A, Waldenstrom  J, Osterhaus  ADME, Fouchier  RAM. Global patterns of influenza A virus in wild birds. Science. 2006;312:3848 and .DOIPubMedGoogle Scholar
  2. Kawaoka  Y, Yamnikova  S, Chambers  TM, Lvov  DK, Webster  RG. Molecular characterization of a new hemagglutinin, subtype-H14, of influenza-A virus. Virology. 1990;179:75967 and .DOIPubMedGoogle Scholar
  3. Fries  AC, Nolting  JM, Bowman  AS, Killian  ML, Wentworth  DE, Slemons  RD. Genomic analyses detect Eurasian-lineage H10 and additional H14 influenza A viruses recovered from waterfowl in the Central United States. Influenza Other Respir Viruses. 2014;8:4938 and .DOIPubMedGoogle Scholar
  4. Fries  AC, Nolting  JM, Danner  A, Webster  RG, Bowman  AS, Krauss  S, Evidence for the circulation and inter-hemispheric movement of the H14 subtype influenza A virus. PLoS ONE. 2013;8 [cited 2015 Jun 22].DOIGoogle Scholar
  5. Nolting  JFA, Slemons  RD, Courtney  C, Hines  N, Pedersen  J. Recovery of H14 influenza A virus isolates from sea ducks in the Western Hemisphere. PLOS Currents Influenza 2012 (Edition 1).
  6. Boyce  WM, Schobel  S, Dugan  VG, Halpin  R, Lin  X, Wentworth  DE, Complete genome sequence of a reassortant H14N2 avian influenza virus from California. Genome Announc. 2013;1:e00543–13.DOIGoogle Scholar
  7. Ramey  AM, Poulson  RL, Gonzalez-Reiche  AS, Perez  DR, Stallknecht  DE, Brown  JD. Genomic characterization of H14 subtype influenza A viruses in new world waterfowl and experimental infectivity in mallards (Anas platyrhynchos). PLoS ONE. 2014;9 [cited 2015 Jun 22].DOIGoogle Scholar
  8. Wilcox  BR, Knutsen  GA, Berdeen  J, Goekjian  V, Poulson  R, Goyal  S, Influenza-A viruses in ducks in northwestern Minnesota: fine scale spatial and temporal variation in prevalence and subtype diversity. PLoS ONE. 2011;6:e24010 and .DOIPubMedGoogle Scholar
  9. Ekiert  DC, Friesen  RHE, Bhabha  G, Kwaks  T, Jongeneelen  M, Yu  WL, A highly conserved neutralizing epitope on group 2 influenza A viruses. Science. 2011;333:84350 and .DOIPubMedGoogle Scholar
  10. Gilbert  M, Koel  BF, Bestebroer  TM, Lewis  NS, Smith  DJ, Fouchier  RAM. Serological evidence for non-lethal exposures of Mongolian wild birds to highly pathogenic avian influenza H5N1 virus. PLoS ONE. 2014;9 [cited 2015 Jun 22].DOIGoogle Scholar




Cite This Article

DOI: 10.3201/eid2112.150413

Related Links


Table of Contents – Volume 21, Number 12—December 2015

EID Search Options
presentation_01 Advanced Article Search – Search articles by author and/or keyword.
presentation_01 Articles by Country Search – Search articles by the topic country.
presentation_01 Article Type Search – Search articles by article type and issue.



Please use the form below to submit correspondence to the authors or contact them at the following address:

Neus Latorre-Margalef, College of Veterinary Medicine, The University of Georgia, 589 D. W. Brooks Dr, Athens, GA 30602, USA

Send To

10000 character(s) remaining.


Page created: November 17, 2015
Page updated: November 17, 2015
Page reviewed: November 17, 2015
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.